7.06
전일 마감가:
$7.01
열려 있는:
$7.21
하루 거래량:
210.89K
Relative Volume:
0.64
시가총액:
$621.35M
수익:
-
순이익/손실:
$-42.63M
주가수익비율:
-13.37
EPS:
-0.5281
순현금흐름:
$-39.43M
1주 성능:
-3.42%
1개월 성능:
-16.15%
6개월 성능:
+69.71%
1년 성능:
+165.41%
Alpha Tau Medical Ltd Stock (DRTS) Company Profile
Compare DRTS vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DRTS
Alpha Tau Medical Ltd
|
7.06 | 616.95M | 0 | -42.63M | -39.43M | -0.5281 |
|
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
|
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Alpha Tau Medical Ltd Stock (DRTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | 개시 | Citigroup | Buy |
| 2023-04-24 | 개시 | H.C. Wainwright | Buy |
| 2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-08 | 개시 | Piper Sandler | Overweight |
| 2022-04-04 | 개시 | Citigroup | Buy |
모두보기
Alpha Tau Medical Ltd 주식(DRTS)의 최신 뉴스
Movement Recap: Should I invest in Alpha Tau Medical Ltd before earningsRisk Management & Target Return Focused Stock Picks - baoquankhu1.vn
Alpha Tau Medical Ltd. (DRTS) Competitors - Meyka
Alpha Tau Medical: 2026 Is The Breakthrough Year - Seeking Alpha
What is the Moat Score of Alpha Tau Medical Ltd2026 Closing Moves & Consistent Return Investment Signals - baoquankhu1.vn
Aug Action: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changes2026 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Is Alpha Tau Medical Ltd forming a bullish divergence2026 Year in Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Alpha Tau Medical (NASDAQ:DRTS) Shares Gap UpHere's Why - MarketBeat
Alpha Tau Medical Conference: Japan Approval, Rolling FDA PMA, and Big 2026 Data Readouts Teased - MarketBeat
Resistance Check: Is Alpha Tau Medical Ltd Equity Warrant benefiting from interest rate changesRate Hike & Daily Volume Surge Signals - baoquankhu1.vn
Alpha Tau Medical (DRTS) director details shares, options and RSUs - Stock Titan
Alpha Tau (DRTS) director discloses initial shares, RSUs and options - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) CEO details equity holdings - Stock Titan
Alpha Tau Medical (DRTS) director Alan Adler details share and option holdings - Stock Titan
Alpha Tau Medical (DRTS) director discloses shares, RSUs and options - Stock Titan
Alpha Tau Medical (DRTS) director details shares, options and warrants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director discloses initial shares, RSUs and option grants - Stock Titan
Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings - Stock Titan
Alpha Tau Medical (DRTS) CFO Raphi Levy reports detailed insider holdings - Stock Titan
Pullback Watch: Can Alpha Tau Medical Ltd Equity Warrant reach all time highs this year2026 Top Gainers & Safe Swing Trade Setups - baoquankhu1.vn
Aug EndMonth: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demandPortfolio Gains Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd stock showing strong momentum2026 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Market Recap: Is Alpha Tau Medical Ltd Equity Warrant stock overvalued or fairly priced2026 Trading Volume Trends & Weekly Stock Breakout Alerts - baoquankhu1.vn
CFO Raphi Levy to pitch Alpha Tau to investors at Sidoti event this week - Stock Titan
Citigroup maintains Alpha Tau Medical (DRTS) buy recommendation - MSN
Alpha Tau Medical to Present at Sidoti March Virtual Small Cap Conference - geneonline.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Nigeria
Alpha Tau Medical’s innovative prostate cancer therapy: study completion update - MSN
Fund Flows: What is the PEG ratio of Alpha Tau Medical Ltd2026 Institutional Moves & Low Risk Entry Point Tips - baoquankhu1.vn
Citigroup Forecasts Strong Price Appreciation for Alpha Tau Medical (NASDAQ:DRTS) Stock - Defense World
HC Wainwright Has Negative Estimate for DRTS Q1 Earnings - Defense World
Short Squeeze: Will Alpha Tau Medical Ltd benefit from rate cuts2026 Fundamental Recap & Low Drawdown Momentum Ideas - baoquankhu1.vn
HC Wainwright Issues Pessimistic Estimate for DRTS Earnings - MarketBeat
Citigroup Increases Alpha Tau Medical (NASDAQ:DRTS) Price Target to $9.00 - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright - Defense World
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses - TipRanks
Alpha Tau Medical (NASDAQ:DRTS) Issues Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
DRTS: Alpha DaRT shows promising efficacy in solid tumors, with pivotal trials and global expansion ongoing - TradingView
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year - TipRanks
Alpha Tau Medical (NASDAQ: DRTS) outlines 2025 loss and Oramed financing - Stock Titan
Alpha Tau (NASDAQ: DRTS) widens 2025 loss but gains Japan approval, $76.9M cash - Stock Titan
Alpha Tau Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Alpha Tau cancer therapy wins Japan nod, targets tough tumors - Stock Titan
DRTS: 2025 net loss widened to $42.6M; cash reserves at $76.9M; pivotal trials and commercialization ongoing - TradingView
Trade Report: Is Alpha Tau Medical Ltd Equity Warrant stock a good pick for beginners2026 Volatility Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Is Alpha Tau Medical Ltd. Equity Warrant benefiting from interest rate changesPortfolio Value Summary & Growth-Oriented Investment Plans - mfd.ru
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives $7.00 Average PT from Analysts - Defense World
Piper Sandler Reaffirms Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Alpha Tau Medical Shares Fall After Piper Sandler Downgrade - marketscreener.com
Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com South Africa
DRTS Receives Downgrade from Piper Sandler with Neutral Rating | - GuruFocus
Alpha Tau Medical Ltd (DRTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):